157 related articles for article (PubMed ID: 9038732)
21. Immunohistochemical expression of p53, bcl-2, and p21(WAF1/CIP1) in early cervical carcinoma: correlation with clinical outcome.
Graflund M; Sorbe B; Karlsson M
Int J Gynecol Cancer; 2002; 12(3):290-8. PubMed ID: 12060451
[TBL] [Abstract][Full Text] [Related]
22. [Expression of metastasis suppressor gene KAI1/CD82 in cervical squamous cell carcinoma and its clinical significance].
Xiong Y; Liang LZ; Yan XJ; Yuan SH; Wei M
Ai Zheng; 2005 Jan; 24(1):110-5. PubMed ID: 15642213
[TBL] [Abstract][Full Text] [Related]
23. The possible role of p53 and bcl-2 expression in cervical carcinomas and their premalignant lesions.
Dimitrakakis C; Kymionis G; Diakomanolis E; Papaspyrou I; Rodolakis A; Arzimanoglou I; Leandros E; Michalas S
Gynecol Oncol; 2000 Apr; 77(1):129-36. PubMed ID: 10739702
[TBL] [Abstract][Full Text] [Related]
24. Immunohistochemical study of cell cycle-associated proteins in adenocarcinoma of the uterine cervix treated with radiotherapy alone: P53 status has a strong impact on prognosis.
Suzuki Y; Nakano T; Kato S; Ohno T; Tsujii H; Oka K
Int J Radiat Oncol Biol Phys; 2004 Sep; 60(1):231-6. PubMed ID: 15337561
[TBL] [Abstract][Full Text] [Related]
25. Expression of cyclins, p53, and Ki-67 in cervical squamous cell carcinomas: overexpression of cyclin A is a poor prognostic factor in stage Ib and II disease.
Shiohara S; Shiozawa T; Miyamoto T; Feng YZ; Kashima H; Kurai M; Suzuki A; Konishi I
Virchows Arch; 2005 Jun; 446(6):626-33. PubMed ID: 15891905
[TBL] [Abstract][Full Text] [Related]
26. p53 in surgically treated and pathologically staged cervical cancer: correlation with local tumor progression, but not with lymphatic spread.
Horn LC; Fischer U; Hänel C; Kuhn H; Raptis G; Bilek K
Pathol Res Pract; 2001; 197(9):605-9. PubMed ID: 11569924
[TBL] [Abstract][Full Text] [Related]
27. Expression and clinical implications of enhancer of Zeste homolog 2 and p53 protein in squamous cell carcinoma and precancerous lesions in the cervix.
Zhang HM; Chen SQ; Yao SZ
Genet Mol Res; 2016 Jun; 15(2):. PubMed ID: 27323178
[TBL] [Abstract][Full Text] [Related]
28. The impact of tumour angiogenesis, p53 overexpression and proliferative activity (MIB-1) on survival in squamous cervical carcinoma.
Avall-Lundqvist EH; Silfverswärd C; Aspenblad U; Nilsson BR; Auer GU
Eur J Cancer; 1997 Oct; 33(11):1799-804. PubMed ID: 9470836
[TBL] [Abstract][Full Text] [Related]
29. nm23-H1 protein immunoreactivity in intraepithelial neoplasia and invasive squamous cell carcinoma of the uterine cervix.
Lee CS; Gad J
Pathol Int; 1998 Oct; 48(10):806-11. PubMed ID: 9788265
[TBL] [Abstract][Full Text] [Related]
30. Semaphorin 4D expression is associated with a poor clinical outcome in cervical cancer patients.
Liu H; Yang Y; Xiao J; Yang S; Liu Y; Kang W; Li X; Zhang F
Microvasc Res; 2014 May; 93():1-8. PubMed ID: 24603190
[TBL] [Abstract][Full Text] [Related]
31. p53 and p21 expression in precancerous lesions and carcinomas of the uterine cervix: overexpression of p53 predicts poor disease outcome.
Huang LW; Chou YY; Chao SL; Chen TJ; Lee TT
Gynecol Oncol; 2001 Nov; 83(2):348-54. PubMed ID: 11606096
[TBL] [Abstract][Full Text] [Related]
32. Expression of BDNF, TrkB, and p53 in early-stage squamous cell carcinoma of the uterine cervix.
Moon A; Won KY; Lee JY; Kang I; Lee SK; Lee J
Pathology; 2011 Aug; 43(5):453-8. PubMed ID: 21670725
[TBL] [Abstract][Full Text] [Related]
33. Biological and clinical significance of NAC1 expression in cervical carcinomas: a comparative study between squamous cell carcinomas and adenocarcinomas/adenosquamous carcinomas.
Yeasmin S; Nakayama K; Rahman MT; Rahman M; Ishikawa M; Katagiri A; Iida K; Nakayama N; Otuski Y; Kobayashi H; Nakayama S; Miyazaki K
Hum Pathol; 2012 Apr; 43(4):506-19. PubMed ID: 21889186
[TBL] [Abstract][Full Text] [Related]
34. p53, retinoblastoma gene product, and cyclin protein expression in human papillomavirus virus DNA-positive cervical intraepithelial neoplasia and invasive cancer.
Amortegui AJ; Meyer MP; Elborne VL; Amin RM
Mod Pathol; 1995 Dec; 8(9):907-12. PubMed ID: 8751330
[TBL] [Abstract][Full Text] [Related]
35. Aberrant expression of cyclin D1 is associated with poor prognosis in early stage cervical cancer of the uterus.
Bae DS; Cho SB; Kim YJ; Whang JD; Song SY; Park CS; Kim DS; Lee JH
Gynecol Oncol; 2001 Jun; 81(3):341-7. PubMed ID: 11371120
[TBL] [Abstract][Full Text] [Related]
36. [Expression of angiotensin II type 1 receptor in cervical squamous cell carcinoma and its clinical significance].
Liao YD; Xu H; Han Q; Lei J; Zhang YY; Wang ZH
Zhonghua Zhong Liu Za Zhi; 2007 May; 29(5):360-4. PubMed ID: 17892132
[TBL] [Abstract][Full Text] [Related]
37. Correlation between human papillomavirus positivity and p53 gene overexpression in adenocarcinoma of the uterine cervix.
Uchiyama M; Iwasaka T; Matsuo N; Hachisuga T; Mori M; Sugimori H
Gynecol Oncol; 1997 Apr; 65(1):23-9. PubMed ID: 9103386
[TBL] [Abstract][Full Text] [Related]
38. DEK overexpression in uterine cervical cancers.
Wu Q; Li Z; Lin H; Han L; Liu S; Lin Z
Pathol Int; 2008 Jun; 58(6):378-82. PubMed ID: 18477217
[TBL] [Abstract][Full Text] [Related]
39. P16INK4A overexpression predicts lymph node metastasis in cervical carcinomas.
Huang LW; Lee CC
J Clin Pathol; 2012 Feb; 65(2):117-21. PubMed ID: 22011452
[TBL] [Abstract][Full Text] [Related]
40. E-cadherin, CD44 and CD44v6 in squamous intraepithelial lesions and invasive carcinomas of the uterine cervix: an immunohistochemical study.
Faleiro-Rodrigues C; Lopes C
Pathobiology; 2004; 71(6):329-36. PubMed ID: 15627844
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
